CoDiagnostics (CODX)
(Delayed Data from NSDQ)
$1.14 USD
0.00 (0.00%)
Updated Apr 25, 2024 04:00 PM ET
After-Market: $1.13 -0.01 (-0.88%) 7:58 PM ET
2-Buy of 5 2
F Value F Growth C Momentum F VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
CODX 1.14 0.00(0.00%)
Will CODX be a Portfolio Killer in April?
Zacks Investment Research is releasing its prediction for CODX based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for CODX
Elevance Health (ELV) Beats Q1 Earnings Estimates
Icon PLC (ICLR) Q4 Earnings Surpass Estimates
CODX: What are Zacks experts saying now?
Zacks Private Portfolio Services
Co-Diagnostics, Inc. (CODX) Reports Q2 Loss, Lags Revenue Estimates
Sharecare, Inc. (SHCR) Reports Q2 Loss, Tops Revenue Estimates
Co-Diagnostics, Inc. (CODX) Reports Q1 Loss, Lags Revenue Estimates
Other News for CODX
Co-Diagnostics, Inc. Announces First Quarter 2024 Earnings Release Date and Webcast
Co-Diagnostics, Inc. to Host Booth and Deliver Presentation at APRC 2024 in Taiwan
Co-Diagnostics, Inc. Inaugurates New Manufacturing Facility in Utah with Ribbon Cutting Event
Co-Diagnostics, Inc. Appoints New President and Other C-Level Positions
Co-Diagnostics appoints Richard Abbott as president